SMPX
protein-codingsmall muscle protein X-linked
Gene summary
This gene encodes a small protein that has no known functional domains. Mutations in this gene are a cause of X-linked deafness-4, and the encoded protein may play a role in the maintenance of inner ear cells subjected to mechanical stress. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2011]
- DFN6
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~52.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010238
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0024771
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0024771
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010238
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0019586
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0019497
Submitter: ClinGen
The relationship between SMPX and X-linked nonsyndromic hearing loss was evaluated using the ClinGen Clinical Validity Framework as of 9/8/17. Variants in SMPX were first reported in humans with the disease as early as 2011 (Schraders et al., 21549342). At least six variants, nonsense and frameshift, have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported at least 8 probands in 5 publications (21549342, 21549336, 21893181, 22911656, 28542515). Variants in this gene segregated with disease in >100 additional family members. The families studied display an expected-X linked inheritance pattern where the hearing loss is earlier onset and more profound in males and slightly less penetrant in females. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is supported by expression studies. Loss of function of SMPX is expected to impact the ability of inner ear hair cells to conduct sound. It is important to note that there were SMPX null mice generated to investigate the effect of the deletion on muscle organization and function, however hearing loss was not studied in these mice (Palmer et al. 2001). In summary, SMPX is definitively associated with X-linked nonsyndromic hearing loss. This classification was approved by the ClinGen Hearing Loss Working Group on 9/12/17.
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Musculoskeletal
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment, which may occur in the prelingual stage in some individuals, may improve outcomes, including speech and language development
Comments: Both prelingual and postlingual onset of deafness has been described, with males described as being affected earlier and more severely
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SMPX variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014332.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 13 | ||||
| missense | 3 | 1 | 31 | 1 | 36 | |
| nonsense | 5 | 2 | 7 | |||
| start loss | 0 | |||||
| frameshift | 4 | 7 | 1 | 12 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 2 | 6 | ||
| Total | 13 | 11 | 36 | 14 | 0 | 74 |
Highest pathogenic variant AF is 0.000013244704
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055147.1 | 3 | MANE Select | |
| Ensembl | ENSP00000368808.3 | 3 | MANE Select | |
| Ensembl | ENSP00000495170.1 | 3 | Standard | |
| Ensembl | ENSP00000493671.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- striated muscle contraction
Cellular Component
- nucleus
- muscle tendon junction
- M band
- costamere
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379494
- Coding exons
- 3
- Length
- 52192
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0417 | 34 | 33.3 | 1.02 | 0.00000240 | 563 |
| Missense (PolyPhen) | 15 | 13.25 | 1.132 | 244 | ||
| Synonymous | -1.47 | 20 | 13.2 | 1.52 | 0.00000110 | 172 |
| Loss of Function | 1.63 | 0 | 3.11 | 0.00 | 1.95e-7 | 60 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in the regulatory network through which muscle cells coordinate their structural and functional states during growth, adaptation, and repair. {ECO:0000250}.;
- Disease
- DISEASE: Deafness, X-linked, 4 (DFNX4) [MIM:300066]: A non- syndromic form of sensorineural, progressive hearing loss with postlingual onset. In affected males, the auditory impairment affects initially high-frequency hearing. It later evolves to become severe to profound and affects all frequencies. Carrier females manifest moderate hearing impairment in the high frequencies. {ECO:0000269|PubMed:21549336, ECO:0000269|PubMed:21549342, ECO:0000269|PubMed:22911656}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- LoFtool
- 0.421
- RVIS EVS
- 0.01
- RVIS percentile EVS
- 54.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Low | Low | Low |